Cargando…
A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo
Overexpression of HER2 has been reported in many types of cancer, making it a perfect candidate for targeted immunotherapy. The combination of two FDA approved monoclonal antibodies (mAbs), trastuzumab and pertuzumab, has more robust anti-tumor activity in patients with HER2-overexpressing breast ca...
Autores principales: | Mohammadi, Mehdi, Jeddi-Tehrani, Mahmood, Golsaz-Shirazi, Forough, Arjmand, Mohammad, Bahadori, Tannaz, Judaki, Mohammad Ali, Shiravi, Fariba, Zare, Hengameh Ahmadi, Haghighat, Farzaneh Notash, Mobini, Maryam, Amiri, Mohammad Mehdi, Shokri, Fazel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927792/ https://www.ncbi.nlm.nih.gov/pubmed/33679691 http://dx.doi.org/10.3389/fimmu.2020.600883 |
Ejemplares similares
-
Generation and Characterization of Novel Diagnostic Mouse Monoclonal Antibodies Against Human Estrogen Receptor Alpha and Progesterone Receptor
por: Hassanzadeh Makoui, Masoud, et al.
Publicado: (2022) -
Characterization of Monoclonal and Polyclonal Antibodies Recognizing Prostate Specific Antigen: Implication for Design of a Sandwich ELISA
por: Raoofi Mohseni, Sahar, et al.
Publicado: (2019) -
Differential Effects of Inhibitory and Stimulatory Anti-HER2 Monoclonal Antibodies on AKT/ERK Signaling Pathways
por: Soltantoyeh, Tahereh, et al.
Publicado: (2018) -
Inhibitory Effect of Polyclonal Antibodies Against HER3 Extracellular Subdomains on Breast Cancer Cell Lines
por: Mansouri-Fard, Samaneh, et al.
Publicado: (2020) -
Epitope Mapping of Human HER2 Specific Mouse Monoclonal Antibodies Using Recombinant Extracellular Subdomains
por: Ghatar, Reza Hosseini, et al.
Publicado: (2017)